Pamgene International B.V.
Provider of peptide microarray-based kinome profiling and associated analysis services for biomarker discovery, preclinical drug research and development of blood-based diagnostic tests. Offers laboratory assay services, custom peptide-array design and bioinformatics for kinase-signaling and patient stratification studies, and collaborates with academic and industry partners on translational and toxicology projects.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Peptide microarray kinase activity profiling platform
Laboratory platform that measures peptide phosphorylation patterns to profile kinase activity across samples; includes peptide arrays, flow-based assay workflow and associated analysis software.
Peptide microarray kinase activity profiling platform
Laboratory platform that measures peptide phosphorylation patterns to profile kinase activity across samples; includes peptide arrays, flow-based assay workflow and associated analysis software.
Services
Laboratory-based in‑vitro diagnostic assay services generating phosphorylation profiles from blood and tissue samples for biomarker studies and diagnostic test validation under a certified quality system.
Custom kinome profiling projects including ex vivo drug panels, target-identification studies and kinome analysis across cell lines, PDX/xenografts and alternative models to support lead optimization and translational research.
Analytical services to infer upstream kinases, perform pathway/network analysis and build predictive models from peptide-array phosphorylation data using public PTM databases and in‑house workflows.
Laboratory-based in‑vitro diagnostic assay services generating phosphorylation profiles from blood and tissue samples for biomarker studies and diagnostic test validation under a certified quality system.
Custom kinome profiling projects including ex vivo drug panels, target-identification studies and kinome analysis across cell lines, PDX/xenografts and alternative models to support lead optimization and translational research.
Analytical services to infer upstream kinases, perform pathway/network analysis and build predictive models from peptide-array phosphorylation data using public PTM databases and in‑house workflows.
Expertise Areas
- Kinase activity profiling
- Biomarker discovery and validation
- Blood-based diagnostic assay development
- Preclinical drug screening and target discovery
Key Technologies
- Peptide microarray kinase assays
- Kinome profiling (PTK and STK)
- PBMC-based phosphorylation assays
- Kinase–substrate inference using PTM databases
News & Updates
Summary white paper mining AACR abstracts (2004–2013) reporting trends in small-molecule kinase inhibitor research, including numbers of compounds and frequently targeted kinases.
Certificate of Approval by Lloyd’s Register for ISO 13485:2016 Quality Management System enabling provision of in‑vitro diagnostic assay services.
Announced closing of a €13 million Series A financing round to advance deployment of diagnostic blood tests for cancer patients treated with immunotherapy.
Awarded European Innovation Council funding to develop and market a blood-based immunotherapy guidance test.
Summary white paper mining AACR abstracts (2004–2013) reporting trends in small-molecule kinase inhibitor research, including numbers of compounds and frequently targeted kinases.
Certificate of Approval by Lloyd’s Register for ISO 13485:2016 Quality Management System enabling provision of in‑vitro diagnostic assay services.
Announced closing of a €13 million Series A financing round to advance deployment of diagnostic blood tests for cancer patients treated with immunotherapy.
Awarded European Innovation Council funding to develop and market a blood-based immunotherapy guidance test.